Literature DB >> 8213302

Can opiate addicts tell us about their relapse risk? Subjective predictors of clinical prognosis.

J Powell1, S Dawe, D Richards, M Gossop, I Marks, J Strang, J Gray.   

Abstract

Given the high relapse rate of opiate addicts following detoxification, it is pertinent to identify whether any subjective variables mediate outcome, since these may then be targets of treatment. The present study assessed personality, cue-elicited craving, outcome expectancies for drug use, and self-efficacy for resisting drug use, in 43 opiate addicts receiving inpatient detoxification in either a specialist drug-dependence unit or a behavioral/general psychiatric ward, within the context of a randomised, controlled-treatment trial. Subjects were followed-up at between 1 and 3 months and again at 6 months after discharge. Frequency of drug use was not predicted by any of the subjective variables at the first follow-up; but at 6 months, subjects with lower self-efficacy and higher positive outcome expectancies were found to be using less often. Latency to first lapse was greater in subjects with higher anxiety and neuroticism scores. Precipitants to the first lapse were identified, but none of the predicted relationships between subjective variables and circumstances of lapse emerged. It is suggested that greater awareness of personal vulnerability may promote effective coping strategies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213302     DOI: 10.1016/0306-4603(93)90065-h

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  3 in total

Review 1.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

2.  The effects of varied extinction procedures on contingent cue-induced reinstatement in Sprague-Dawley rats.

Authors:  Deanne M Buffalari; Matthew W Feltenstein; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2013-06-18       Impact factor: 4.530

Review 3.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.